EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic accuracy of Savanna RVP4 (QuidelOrtho) for the detection of Influenza A virus, RSV, and SARS-CoV-2

Büsra Köse, Frieder Schaumburg iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.01153-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Büsra Köse und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology, University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Influenza A virus, Influenza, Human. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Seasonal increase of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus A/B (Flu A/B), and respiratory syncytial virus (RSV) require rapid diagnostic test methods for the management of respiratory tract infections. In this study, we compared the diagnostic accuracy of Savanna RVP4 (RVP4, QuidelOrtho) with Xpert Xpress Plus SARS-CoV-2/Flu/RSV (Xpert, Cepheid). Nasopharyngeal swabs from patients treated at a tertiary care hospital (Germany) were tested for SARS-CoV-2, Flu A/B, and RSV by RVP4 to assess diagnostic accuracy (reference standard: Xpert). The intra and inter assay precision of Ct-values was assessed by repeated test in triplicates (on day 1) and duplicates (days 2–3). All patients with a physician’s order for a multiplex test for SARS-CoV-2, Flu, and RSV test were included. Duplicate swabs from the same patient, samples with a total volume ≤1 mL, or inappropriate shipment/storage were excluded. In total, 229 swabs were included between September 2023 and February 2024. The concordance between both tests was 96.5% (SARS-CoV-2), 98.7% (Flu A), and 99.6% (RSV). Flu B was not detected by both tests. The RVP4 test had a sensitivity of 85%–95% and a specificity of 100% for the detection of SARS-CoV-2, Flu A, and RSV. The intra and inter assay precision of Ct-values from RVP4 was 3% and 2% (SARS-CoV-2), 5% and 4% (Flu A), and 0% and 3% (RSV), respectively. The Savanna RVP4 has a favorable diagnostic accuracy for the detection of SARS-CoV-2, Flu A, and RSV. IMPORTANCE We assessed the diagnostic accuracy of a new point-of-care test for the rapid detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus A/B (Flu A/B), and respiratory syncytial virus (RSV). The new test has a concordance with the reference standard of 96.5% (SARS-CoV-2), 98.7% (Flu A), and 99.1% (RSV). The sensitivity of 85%–95% and specificity of 100% for the detection of SARS-CoV-2, Flu A, and RSV is comparable with similar nucleic acid amplification-based point of care tests but at lower costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Influenza A virusInfluenza, HumanSensitivity and SpecificityRespiratory Syncytial Virus InfectionsHumansInfluenza B virusNasopharynxFemaleRespiratory Syncytial Virus, HumanMiddle AgedMaleAdultAgedRespiratory Tract InfectionsGermanyRespiratory Syncytial Viruses

Stichwörter der Autor:innen

Influenza A virusInfluenza B virusSARS-CoV-2multiplex polymerase chain reactionpoint-of-care testingrespiratory syncytial virus

Autor:innen und Institutionen

  • Institute of Medical Microbiology, University Hospital Münster, Münster, Germany.

ORCID-Profile: Frieder Schaumburg

Zitieren

APA

Köse, B., & Schaumburg, F. (2024). Diagnostic accuracy of Savanna RVP4 (QuidelOrtho) for the detection of Influenza A virus, RSV, and SARS-CoV-2. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01153-24

Vancouver

Köse B, Schaumburg F. Diagnostic accuracy of Savanna RVP4 (QuidelOrtho) for the detection of Influenza A virus, RSV, and SARS-CoV-2. Microbiology Spectrum. 2024. doi:10.1128/spectrum.01153-24

BibTeX
@article{Kse2024,
  author = {Köse, Büsra and Schaumburg, Frieder},
  title = {Diagnostic accuracy of Savanna RVP4 (QuidelOrtho) for the detection of Influenza A virus, RSV, and SARS-CoV-2},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.01153-24}
}
Kostenlos starten →